InvestorsObserver is giving BioDelivery Sciences International, Inc. (BDSI) an Analyst Rating Rank of 78, meaning BDSI is ranked higher by analysts than 78% of stocks. The average price target for BDSI is $7.083 and analyst’s rate the stock as a Strong Buy
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With BioDelivery Sciences International, Inc. Stock Today?
BioDelivery Sciences International, Inc. (BDSI) stock has gained 3.7% while the S&P 500 is down -0.19% as of 11:37 AM on Friday, Mar 19. BDSI has risen $0.13 from the previous closing price of $3.65 on volume of 759,367 shares. Over the past year the S&P 500 is up 62.20% while BDSI has risen 11.80%. BDSI earned $0.24 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 15.47.
Click Here to get the full report on BioDelivery Sciences International, Inc. (BDSI) Stock.